Neuralink
N1 implant ("Telepathy"): a coin-sized wireless chip whose ultra-thin electrode threads are stitched into the motor cortex by a surgical robot.
Status, money & milestones
- Status
- Investigational. FDA IDE for its first-in-human study (May 2023); FDA Breakthrough Device designations for Blindsight (vision) and for speech. Trials in the US, Canada, UK and UAE. Reuters: FDA clearance, 25 May 2023 Neuralink: Blindsight designation, Sep 2024 Neuralink: speech designation, 2025
- Count
- 21 participants enrolled worldwide; no newer official total published Neuralink: "Two Years of Telepathy", 27 Jan 2026
- Money
- $650M Series E (June 2025). Reported valuation ~$9B at that round. Neuralink, 2 Jun 2025
Milestones
- First human implant (PRIME study) Reuters
- VOICE trial: a participant with ALS, Terry, speaks through the implant ("I love you") MobiHealthNews
- 11.32 BPS record with weeks-long decoding without recalibration Neuralink
